Heart failure. Heart failure
Conditions
Interventions
Intervention 1: Intervention group1: This group carries out continuous aerobic exercise. Continuous aerobic exercise program (with intensity of 45-70% of maximum heart rate) for 8 weeks (3 sessions p
Sponsors
Islamic Azad University, Neyshabour Branch
Eligibility
Sex/Gender
Male
Age
50 Years to 60 Years
Inclusion criteria
Inclusion criteria: Men aged 50-60 years old with heart failure grade 1-3 according to New York Heart Association (NYHA) criteria; have a heart power of less than 45% and in terms of physical fitness; have potential for exercises.
Exclusion criteria
Exclusion criteria: Having a history of heart disease less than 5 years old, having regular exercise regularly during the past six months, and performing other exercises along with the exercises during the study period, patient dissatisfaction with continued participation in the study; exacerbation of symptoms of heart failure; cardiac arrhythmias; cardiac ischemia; high blood pressure crisis; neurological problems; orthopedic problems.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum IL-6 level. Timepoint: At the beginning of the study and 8 weeks after the intervention. Method of measurement: Serum concentrations of IL-6 (pg/ml), Using high-sensitivity ELISA kits.;Serum TNF-a level. Timepoint: At the beginning of the study and 8 weeks after the intervention. Method of measurement: Serum concentrations of TNF-a (pg/ml), Using high-sensitivity ELISA kits.;Serum hs-CRP level. Timepoint: At the beginning of the study and 8 weeks after the intervention. Method of measurement: Serum concentrations of hs-CRP (ml/l), Using high-sensitivity ELISA kits.;Serum ICAM-1 level. Timepoint: At the beginning of the study and 8 weeks after the intervention. Method of measurement: Serum concentrations of ICAM -1 (ng/ml), Using high-sensitivity ELISA kits.;Serum VCAM-1 level. Timepoint: At the beginning of the study and 8 weeks after the intervention. Method of measurement: Serum concentrations of VCAM -1 (ng/ml), Using high-sensitivity ELISA kits.;Serum E-selectin level. Timepoint: At the beginning of the study and 8 weeks after the intervention. Method of measurement: Serum concentrations of E-selectin (ng/ml), Using high-sensitivity ELISA kits.;Serum P-selectin level. Timepoint: At the beginning of the study and 8 weeks after the intervention. Method of measurement: Serum concentrations of P-selectin (ng/ml), Using high-sensitivity ELISA kits. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLadan Hosseni Abrishami
Islamic Azad University, Neyshabour Branch
Outcome results
None listed